For the first time, our results revealed that NRF2 bound to the GCLC promoter, and that knockdown of CAV1 or overexpression of NRF2 activated the transcription of GCLC, promoting the biosynthesis of GSH and inhibiting ferroptosis in DCM (Figure 7). The gene discussed is GCLC; the disease is familial dilated cardiomyopathy.